Letters New drugs for hyponatraemia

Authors’ reply

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2445 (Published 18 April 2011) Cite this as: BMJ 2011;342:d2445
  1. Anjali Amin, specialist registrar, diabetes and endocrinology1,
  2. Karim Meeran, professor of endocrinology1
  1. 1Imperial Centre for Endocrinology, London W6 8RF, UK
  1. a.amin{at}imperial.ac.uk
  • Competing interests: None declared.

Grant suggests that tolvaptan could reduce hospital stay in acute neurosurgical patients,1 but quotes a study on patients with heart failure.2 He indicates that one tolvaptan tablet could reduce hospital stay by more than two days. But the study found that daily administration …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe